Edition:
United States

Hofseth Biocare ASA (HOFBC.OL)

HOFBC.OL on Oslo Stock Exchange

1.82NOK
26 May 2017
Change (% chg)

kr0.07 (+4.00%)
Prev Close
kr1.75
Open
kr1.78
Day's High
kr1.82
Day's Low
kr1.78
Volume
11,000
Avg. Vol
208,391
52-wk High
kr2.50
52-wk Low
kr1.16

Summary

Name Age Since Current Position

Roger Hofseth

43 2016 Chairman of the Board

Tor Andersen

2016 Chief Executive Officer

Jon Odegard

2016 Chief Financial Officer

Matt Mixter

Managing Director of Hofseth, LLC

Bomi Framroze

56 2010 Chief Scientific Officer

Kai Thuen

2014 Marketing Manager

Henriette Godo Heggdal

36 2015 QA/QC Manager, Director

Oddvar Myrmo

52 2012 Plant Manager Berkak

Roald Rogne

47 2012 Plant Manager Midsund

Christoph Baldegger

2015 Independent Director

Torill Standal Eliassen

2015 Independent Director

Biographies

Name Description

Roger Hofseth

Mr. Roger Hofseth has served as Chairman of the Board of Hofseth Biocare ASA since May 26, 2016. He has been Acting Chairman of the Board since January 4, 2016. He has been Director of the Company since October 2011 and from incorporation of the Company in 2009 until June 2010. In 2001, he incorporated Hofseth Invest AS, which represented the beginning for the Hofseth group. He has 20 years of experience in the fishery and food industry. His experience includes the founding of a number of companies and holding the position as Member of the Board and/or Management position in a number of companies within the fishery, fish farming and ecological food industry. He currently holds directorships, supervisory or management positions (other than positions in the Company and/or its subsidiaries) as Chairman of Norsk Fisketerminal AS, Chairman of Roger Hofseth AS, Chairman of Tyco Invest AS, Board Member of Syvde Eiendom AS, Board Member of Hofseth AS, CEO of Hofseth International AS, Board Member of Hofseth International AS and Board member of Seafood Farmers of Norway AS. He is also Board Member of Vanylven Vekst HF.

Tor Andersen

Mr. Tor Erik Andersen has been Chief Executive Officer at Hofseth Biocare ASA since August 2016. He has previously served as Chief Operating Officer of the Company since September 14, 2015. Mr. Andersen previously held the position as Managing Director and Senior Vice President in Western Bulk Pte. Ltd, Singapore, where he was based during 2005-2014. Prior to this he was Chartering Manager in Western Bulk Carriers, Oslo. Mr. Andersen holds a Master of Science in Maritime Operations from John Moore’s University of Liverpool, England, and a Bachelor of Science in Nautical Studies from Aalesund College.

Jon Odegard

Mr. Jon Olav Odegard has been Chief Financial Officer of Hofseth BioCare ASA since August 2016. He has previously been Chief Executive Officer of the Company from March 1, 2013. Before HBC, he had the position as managing director of Factoring in the SpareBank 1 Group, where he was responsible for strategy and business development, compliance and risk management among other things. Further, Odegard has worked as an adviser specialized in process and efficiency improvement in a number of industries. Mr. Odegard holds a MBA from Norwegian School of Management.

Matt Mixter

Mr. Matt Mixter serves as Managing Director of Hofseth, LLC within Hofseth Biocare ASA. Matt is the managing director of US office based in Chicago, IL. He is responsible for developing and executing the strategy and positioning of HBC products in the US market. With almost a decade of diverse experience in the seafood industry and over 5 years of dealing with sister company Hofseth International, Matt brings a wealth of knowledge and proven success to the HBC organization.

Bomi Framroze

Dr. Bomi Framroze has served as Chief Scientific Officer of Hofseth Biocare ASA since 2010. Dr. Framroze is a Discovery scientist with over 40 worldwide patents and publications in Life Science and Chemical software research. He has been an Associate Director of Chemical Discovery at American Cyanamid, an Executive Director at Gharda Chemicals Ltd. and was Founder/CSO of Row2Technologies Inc. Since 2004 he has been carrying out Discovery research in process technologies, biochemistry and marine ingredients.

Kai Thuen

Mr. Kai Morten Thuen has been Marketing Manager at Hofseth Biocare ASA since August 2014. Mr. Thuen has his past experience from telecommunication. Before Hofseth BioCare he worked seven years for Hello AS where he was involved in nearly every part of the organization, from customer care, sales, quality management and marketing. Furthermore, Thuen previously worked for Skandiabanken and NextGenTel. Thuen has his education from BI in Alesund and DPH, now NITH, in Bergen.

Henriette Godo Heggdal

Mrs. Henriette Godo Heggdal has been Director of Hofseth Biocare ASA since December 27, 2013. She has also been QA/QC Manager at the Company since February 1, 2015. She has served at Hofseth Biocare ASA as Laboratory leader/ Quality leader since 2010; Molde hospital as department for Medical Biochemistry (May 2010 - December 2010), Green Earth Industries as Laboratory leader/ Quality leader (April 2008 - April 2009), Molde hospital at department for Medical Biochemistry (December 2006 - April 2008), Molde hospital at department for Medical Biochemistry (Temp.) (May 2003 - October 2005), Children’s Allergy program in Trondheim NTNU - part-time (September 2003 - June 2004). She is Bioengineer (authorization) from Hogskolen i Sor Trondelag as Bioengineer (2001-2004).

Oddvar Myrmo

Mr. Oddvar Myrmo has served as Plant Manager Berkak at Hofseth Biocare ASA since December 2012. Until then, he worked at the factory in Berkak for the last 5 years. He has nearly 20 years experience from food technology. Mr. Myrmo has long experience as Production Manager in the Norwegian Dairy Industry. He also has experience from Quality Management in Food Industry. Myrmo received his education at HiST, Trondheim. Former employment at TINE SA as Production Manager and Nortura as Production Manager.

Roald Rogne

Mr. Roald Rogne has served as Plant Manager Midsund at Hofseth Biocare ASA since January 2012. He has more than 20 years of experience from the fishing gear production (MoreNot AS) and the fishing production industry. He has held positions as Quality Manager, Project Manager and Production Planner. He was HS&E Manager of Firmenich Bjorge Biomarine.

Christoph Baldegger

Mr. Christoph Baldegger has been Independent Director at Hofseth Biocare ASA since May 26, 2015. Since 2008 he is founding member, board member and managing director of Bonafide. From 2004 to 2008 he was a member of the management of a private equity company, where he was co-responsible for the setup of real asset investments in the fields of fish farming, farming and timber. From 1998 to 2004 he was able to put his know-how into practice in research, development and advisory services as well as a fund manager at Swiss private banks. From 1990 to 1998 he worked as an investment banker in Switzerland and London. Christoph Baldegger is a certified European financial analyst (CEFA). Mr. Baldegger has expertise in aquaculture and fishery; attendance of a Specialized Professional Training FBA on aquaculture at the Zurich University of Applied Sciences; holding of own fishing grounds by lease; international experience and network in different fields; establishment of an aquaculture in South America; leadership skills and marketing expertise; establishment of Bonafide; launch of the Bonafide Global Fish Fund and Deep Blue Ventures Fund. He is Board Member and CEO of Bonafide and Director of Bonafide Hong Kong Ltd.

Torill Standal Eliassen

Mrs. Torill Standal Eliassen has been Independent Director at Hofseth Biocare ASA since May 26, 2015. Mrs. Eliassen has a diploma in international marketing and exports from BI Norwegian Business School and Ecole Superieure de Commerce in France. Her main experience is within sales and marketing from the Pharmaceutical Industry in Norway, France, Belgium and Luxemburg. In Mrs. Eliassen’s career she has been a part of several company acquisitions, mergers and cultural changes within Nycomed- Amersham, Amersham Health and General Electrics. After more than 10 years in the Pharmaceutical Industry, Mrs. Eliassen converted into the IT- business in 2014 where she currently holds the position as Sales and Marketing Director in Avento AS.

Basic Compensation

Name Fiscal Year Total

Roger Hofseth

542,000

Tor Andersen

392,000

Jon Odegard

1,774,000

Matt Mixter

1,090,000

Bomi Framroze

5,266,000

Kai Thuen

902,000

Henriette Godo Heggdal

856,000

Oddvar Myrmo

830,000

Roald Rogne

1,097,000

Christoph Baldegger

56,000

Torill Standal Eliassen

56,000
As Of  30 Dec 2015